| |
| |
|
| Insider
Information: |
Robin Sherrington |
| Relationship: |
|
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
8,398 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,398 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
|
2024-03-07 |
8,398 |
2015-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2024-03-07 |
4 |
S |
$46.15 |
$330,290 |
D/D |
(7,137) |
8,398 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2024-03-07 |
4 |
D |
$45.96 |
$69,124 |
D/D |
(1,504) |
15,535 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2024-03-07 |
4 |
OE |
$9.85 |
$85,114 |
D/D |
8,641 |
16,824 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2023-12-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,398) |
8,398 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-09-01 |
4 |
S |
$38.03 |
$1,675,476 |
D/D |
(43,879) |
16,796 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-09-01 |
4 |
D |
$38.81 |
$237,556 |
D/D |
(6,121) |
60,675 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-09-01 |
4 |
OE |
$4.75 |
$237,500 |
D/D |
50,000 |
66,796 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-08-31 |
4 |
OE |
$2.67 |
$70,443 |
D/D |
22,488 |
39,720 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-08-31 |
4 |
D |
$37.86 |
$59,516 |
D/D |
(1,572) |
38,148 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-08-31 |
4 |
S |
$38.57 |
$823,547 |
D/D |
(21,352) |
16,796 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-03-04 |
4 |
S |
$30.15 |
$662,208 |
D/D |
(21,710) |
17,232 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-03-04 |
4 |
OE |
$3.67 |
$27,180 |
D/D |
7,406 |
38,942 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2022-03-04 |
4 |
D |
$31.42 |
$21,868 |
D/D |
(696) |
32,770 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2021-05-28 |
4 |
S |
$18.81 |
$114,120 |
D/D |
(6,067) |
32,232 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2021-05-28 |
4 |
D |
$18.91 |
$79,725 |
D/D |
(4,216) |
38,299 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2021-05-28 |
4 |
OE |
$3.76 |
$97,907 |
D/D |
25,719 |
40,491 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2020-06-01 |
4 |
D |
$13.70 |
$22,331 |
D/D |
(1,630) |
16,796 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2020-06-01 |
4 |
OE |
$3.56 |
$29,299 |
D/D |
8,230 |
18,426 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2019-09-12 |
4 |
D |
$9.38 |
$17,522 |
D/D |
(1,868) |
10,196 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Strategy & Innovation |
• – – |
2019-09-12 |
4 |
OE |
$3.07 |
$18,948 |
D/D |
6,172 |
12,064 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP Bus. & Corp. Development |
• – – |
2018-03-15 |
4 |
OE |
$3.77 |
$11,634 |
D/D |
3,086 |
7,820 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP Bus. & Corp. Development |
• – – |
2018-03-15 |
4 |
D |
$4.63 |
$8,917 |
D/D |
(1,928) |
5,892 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
SVP Bus. & Corp. Development |
• – – |
2017-05-12 |
4 |
D |
$4.18 |
$5,622 |
D/D |
(1,345) |
4,734 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
SVP Bus. & Corp. Development |
• – – |
2017-05-12 |
4 |
OE |
$3.21 |
$6,603 |
D/D |
2,057 |
6,079 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
SVP Bus. & Corp. Development |
• – – |
2015-12-16 |
4 |
D |
$7.94 |
$1,818 |
D/D |
(229) |
4,022 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
